Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,332,566
+$310,702 QoQ
Shares Held
1,111
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#2,865
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLC Capital Advisors holds $21,615,806 across 11 Drug Manufacturers - General names. LLY ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
86,579 | $11,125,401 | |
| 2 | JNJ |
Johnson & Johnson
|
13,403 | $3,403,959 | |
| 3 | PFE |
Pfizer Inc
|
66,092 | $1,591,495 | |
| 4 | ABBV |
AbbVie Inc.
|
6,063 | $1,525,693 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,111 | $1,332,566 | |
| 6 | AMGN |
Amgen Inc
|
2,086 | $755,382 | |
| 7 | NVS |
Novartis AG
|
3,066 | $480,503 | |
| 8 | NVO |
Novo Nordisk A S
|
9,824 | $470,962 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,332,566 | 1,111 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,021,864 | 1,111 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,254,151 | 1,167 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $870,583 | 1,141 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $866,057 | 1,111 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $842,428 | 1,020 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $798,248 | 1,034 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,000,226 | 1,129 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,031,227 | 1,139 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $921,104 | 1,184 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $700,669 | 1,202 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $645,630 | 1,202 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $594,666 | 1,268 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $438,890 | 1,278 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $467,543 | 1,278 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $419,061 | 1,296 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $571,617 | 1,763 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $504,870 | 1,763 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $486,975 | 1,763 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $407,341 | 1,763 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $404,643 | 1,763 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $329,363 | 1,763 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $314,548 | 1,863 | Shares | Sole | 2021-02-10 | |
| 2020-03-31 | $213,628 | 1,540 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||